| # | Drug | Count |
|---|---|---|
| 0 | ALEMTUZUMAB | 405 |
| 1 | RITUXIMAB | 137 |
| 2 | PREDNISONE | 130 |
| 3 | NIVOLUMAB | 106 |
| 4 | METHYLPREDNISOLONE | 86 |
| 5 | BISOPROLOL FUMARATE | 83 |
| 6 | FUROSEMIDE | 82 |
| 7 | PREDNISOLONE | 81 |
| 8 | PREDNISOLONE ORAL | 81 |
| 9 | PREDNISOLONE ORAL SOLUTION | 81 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALEMTUZUMAB | 405 | 0.0209 |
| 1 | ROMIPLOSTIM | 61 | 0.0040 |
| 2 | ELTROMBOPAG OLAMINE | 60 | 0.0026 |
| 3 | DANAZOL | 7 | 0.0025 |
| 4 | GAUNFACINE | 9 | 0.0024 |
| 5 | CALCIUM FOLINATE | 11 | 0.0023 |
| 6 | PALONOSETRON HYDROCHLORIDE | 11 | 0.0020 |
| 7 | FLUDARABINE PHOSPHATE | 70 | 0.0018 |
| 8 | AMISULPRIDE | 10 | 0.0016 |
| 9 | DACARBAZINE | 12 | 0.0016 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 405 |
| 1 | Corticosteroid [EPC] | 364 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 171 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 160 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 147 |
| 5 | Proton Pump Inhibitor [EPC] | 131 |
| 6 | Platinum-based Drug [EPC] | 125 |
| 7 | Factor Xa Inhibitor [EPC] | 100 |
| 8 | Loop Diuretic [EPC] | 93 |
| 9 | Alkylating Drug [EPC] | 89 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 405 | 0.0209 |
| 1 | Thrombopoietin Receptor Agonist [EPC] | 61 | 0.0040 |
| 2 | Provitamin D2 Compound [EPC] | 64 | 0.0022 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 171 | 0.0017 |
| 4 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 5 | Dopamine-2 Receptor Antagonist [EPC] | 10 | 0.0013 |
| 6 | Antifibrinolytic Agent [EPC] | 12 | 0.0012 |
| 7 | Monobactam Antibacterial [EPC] | 3 | 0.0011 |
| 8 | CD33-directed Immunoconjugate [EPC] | 4 | 0.0011 |
| 9 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |